Related Experiment Video
Updated: Mar 9, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Angiotensin II-AT1-receptor signaling is necessary for cyclooxygenase-2-dependent postnatal nephron generation
Stefanie Frölich1, Patrick Slattery1, Dominique Thomas1
1Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.
Abstract:
Deletion of cyclooxygenase-2 (COX-2) causes impairment of postnatal kidney development. Here we tested whether the renin angiotensin system contributes to COX-2-dependent nephrogenesis in mice after birth and whether a rescue of impaired renal development and function in COX-2-/- mice was achievable. Plasma renin concentration in mouse pups showed a birth peak and a second peak around day P8 during the first 10 days post birth. Administration of the angiotensin II receptor AT1 antagonist telmisartan from day P1 to P3 did not result in cortical damage. However, telmisartan treatment from day P3 to P8, the critical time frame of renal COX-2 expression, led to hypoplastic glomeruli, a thinned subcapsular cortex and maturational arrest of superficial glomeruli quite similar to that observed in COX-2-/- mice. In contrast, AT2 receptor antagonist PD123319 was without any effect on renal development. Inhibition of the renin angiotensin system by aliskiren and enalapril caused similar glomerular defects as telmisartan. Administration of the AT1 receptor agonist L162313 to COX-2-/- pups improved kidney growth, ameliorated renal defects, but had no beneficial effect on reduced cortical mass. L162313 rescued impaired renal function by reducing serum urea and creatinine and mitigated pathologic albumin excretion. Moreover, glomerulosclerosis in the kidneys of COX-2-/- mice was reduced. Thus, angiotensin II-AT1-receptor signaling is necessary for COX-2-dependent normal postnatal nephrogenesis and maturation.
Insights
Cyclooxygenase-2 (COX-2) is crucial for kidney development. Blocking the renin-angiotensin system impairs kidney maturation in mice, but activating angiotensin II-AT1 receptors can rescue function and reduce damage in COX-2 deficient kidneys.
Area of Science:
- Nephrology
- Developmental Biology
- Pharmacology
Background:
- Cyclooxygenase-2 (COX-2) plays a vital role in postnatal kidney development.
- The renin-angiotensin system's involvement in COX-2-dependent nephrogenesis is not fully understood.
Purpose of the Study:
- To investigate the contribution of the renin-angiotensin system to COX-2-dependent kidney development in mice.
- To determine if impaired renal development and function in COX-2 deficient mice can be rescued.
Main Methods:
- Administered angiotensin II receptor AT1 antagonist telmisartan, AT2 receptor antagonist PD123319, renin inhibitor aliskiren, and ACE inhibitor enalapril to mouse pups.
- Administered AT1 receptor agonist L162313 to COX-2 deficient (COX-2-/-) mouse pups.
- Assessed renal development, glomerular morphology, renal function (serum urea, creatinine), albumin excretion, and glomerulosclerosis.
Main Results:
- Telmisartan treatment during critical postnatal periods mimicked the renal defects observed in COX-2-/- mice, including hypoplastic glomeruli and maturational arrest.
- Inhibition of the renin-angiotensin system by aliskiren and enalapril also caused similar glomerular defects.
- L162313 administration improved kidney growth, ameliorated renal defects, rescued impaired renal function, and reduced glomerulosclerosis in COX-2-/- mice, though it did not increase cortical mass.
Conclusions:
- Angiotensin II-AT1 receptor signaling is essential for normal COX-2-dependent postnatal kidney development and maturation.
- Targeting the renin-angiotensin system, specifically the AT1 receptor, holds potential for therapeutic intervention in conditions with impaired nephrogenesis.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Endocrine Signaling
Regulation of Angiogenesis and Blood Supply
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation
Antihypertensive Drugs: Direct Renin Inhibitors

